BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Briquilimab readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Briquilimab\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT04784052-3549@assetmemo.bio
DTSTAMP:20261121T005834Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:Briquilimab: Phase 1/2 readout est. (NCT04784052)
DESCRIPTION:Briquilimab\, phase 1/2.\nStudy: Depleted Donor Stem Cell Trans
 plant in Children and Adults With Fanconi Anemia After Being Conditioned W
 ith a Regimen Containing Briquilimab\nEstimated primary completion: Decemb
 er 2027. This is a ClinicalTrials.gov estimate\, not a confirmed readout d
 ate\, and it can move.\nDrug page: https://assetmemo.bio/drug/briquilimab#
 upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT0478
 4052
URL:https://assetmemo.bio/drug/briquilimab#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05600907-3549@assetmemo.bio
DTSTAMP:20261121T005834Z
DTSTART;VALUE=DATE:20361130
DTEND;VALUE=DATE:20361201
SUMMARY:Briquilimab: Phase 1 readout est. (NCT05600907)
DESCRIPTION:Briquilimab\, phase 1.\nStudy: Study to Assess the Use of JSP19
 1 in Matched Unrelated Donor Transplantation for Chronic Granulomatous Dis
 ease (CGD)\nEstimated primary completion: 30 November 2036. This is a Clin
 icalTrials.gov estimate\, not a confirmed readout date\, and it can move.\
 nDrug page: https://assetmemo.bio/drug/briquilimab#upcoming-events\nRegist
 ry record: https://clinicaltrials.gov/study/NCT05600907
URL:https://assetmemo.bio/drug/briquilimab#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
